Randomized trial of a low-molecular-weight heparin (Kabi 2165) versus adjusted-dose subcutaneous standard heparin in the prophylaxis of deep-vein thrombosis after elective hip surgery.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples